| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/28/2008 | US20080206162 Composition and Methods for Treating Alzheimer's Disease and Other Amyloidoses |
| 08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | CA2678618A1 Modulation of nkt cell activity with antigen-loaded cd1d molecules |
| 08/28/2008 | CA2677573A1 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
| 08/28/2008 | CA2672716A1 Novel therapeutic use for treating leukaemia |
| 08/27/2008 | EP1962094A1 Detecting agent and therapeutic agent for highly malignant breast cancer |
| 08/27/2008 | EP1961767A2 Diagnosis and treatment of cancers and other conditions |
| 08/27/2008 | EP1961754A1 Bicyclic heterocyclic compound |
| 08/27/2008 | EP1961745A1 Bicyclic heterocyclic compound |
| 08/27/2008 | EP1961428A1 SC6 antibody for treatment of cancer |
| 08/27/2008 | EP1959969A2 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 08/27/2008 | EP1959958A1 Integrin-binding small molecules |
| 08/27/2008 | EP1959954A2 Compositions and methods for treating cns disorders |
| 08/27/2008 | EP1596810B1 Use of banana extract for the treatment of inflammatory bowel disease |
| 08/27/2008 | EP1526850B1 Use of vitamin C for the treatment of Charcot-Marie-Tooth disease |
| 08/27/2008 | EP1408981B1 Methods for preventing antipsychotic-induced weight gain |
| 08/27/2008 | EP1392284B1 Methods of treating hyperlipidemia |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1313714B1 Valsartan salts |
| 08/27/2008 | EP1234025B1 Human enzymes of the metalloprotease family |
| 08/27/2008 | EP1027437B1 Uses of the wnt-1 induced secreted polypeptide wisp-1 |
| 08/27/2008 | EP0952832B1 Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors |
| 08/27/2008 | EP0949931B1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases |
| 08/27/2008 | EP0932665B1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity |
| 08/27/2008 | EP0827410B1 Method for introducing and expressing genes in animal cells |
| 08/27/2008 | CN101252952A Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 08/27/2008 | CN101252940A Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 08/27/2008 | CN101249266A Nano liver target direction amphipathic nature block copolymers drug administration system and preparation |
| 08/27/2008 | CN101249066A Sustained-release agent containing hormone anti-cancer medicine |
| 08/27/2008 | CN100413852C Valsartan salts |
| 08/27/2008 | CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 08/27/2008 | CN100413538C Remedy for corneal failure |
| 08/27/2008 | CN100413506C Improved pharmaceutical compositions |
| 08/27/2008 | CN100413490C Insoluble medicine transdemal absorption preparation and process for preparing same |
| 08/26/2008 | US7417118 Pharmaceutical composition containing artificial oxygen carrier |
| 08/26/2008 | US7417051 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt |
| 08/26/2008 | US7417039 Use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/26/2008 | US7417038 administering to the patient an effective amount of an agent which reduces sympathetic nervous system activity; a beta receptor blocker or a compound which inhibits the effect of aldosterone |
| 08/26/2008 | US7417037 Ulcerative colitis and Crohn's disease; 5-aminosalicylic acid or 4-aminosalicylic acid and one or more antioxidants (e.g., N-acetylcysteine) |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 08/26/2008 | US7417023 Targeted delivery of bioaffecting compounds for the treatment of cancer |
| 08/26/2008 | US7417013 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416849 HBM variants that modulate bone mass and lipid levels |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416744 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 08/26/2008 | US7416741 Administering a mono-, di- , tri-, or, preferably, tetrathiomolybdate that binds/complexes endogenous copper to form an irreversible tripartite agent-copper-protein complex; chelation; side effect reduction; pulmonary, cystic, pancreatic, myocardial, gastrointestinal fibrosis, acute respiratory distress |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416726 Cytotoxicity; therapeutic antibody |
| 08/26/2008 | US7416724 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 08/26/2008 | US7416723 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 08/26/2008 | US7416306 Laser projector |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2378487C Antibiotic(s)-polymer combination |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2284909C Medical food for diabetics |
| 08/26/2008 | CA2277112C Use of exendins and agonists thereof for the reduction of food intake |
| 08/26/2008 | CA2239780C A process for regulating vagal tone |
| 08/26/2008 | CA2152401C Synergising association having an antagonist effect on nk1 and nk2 receptors |
| 08/21/2008 | WO2008100450A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| 08/21/2008 | WO2008100240A2 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
| 08/21/2008 | WO2008099907A1 Therapeutic agent for urinary excretion disorder |
| 08/21/2008 | WO2008099906A1 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 08/21/2008 | WO2008099829A1 Method for formation of intestinal adhesion in experimental animal, method for production of experimental animal having intestinal adhesion, method for screening of intestinal adhesion-preventing agent, and intestinal adhesion-preventing agent |
| 08/21/2008 | WO2008099805A1 Central circulation-improving agent |
| 08/21/2008 | WO2008099804A1 Therapeutic agent for diabetic cataract |
| 08/21/2008 | WO2008099615A1 Pharmaceutical composition containing fine particle oil-based suspension |
| 08/21/2008 | WO2008099144A2 Tgf-beta stimulant and further agent to reduce side effects |
| 08/21/2008 | WO2008099001A1 Use of a leukocyte diminishing or inactivating agent in combination with bacterially-mediated tumor treatment |
| 08/21/2008 | WO2008098871A2 Use of chitosans for the treatment of nail inflammatory diseases |
| 08/21/2008 | WO2008098869A2 Use of chitosans to increase nail growth rate |
| 08/21/2008 | WO2008098379A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 08/21/2008 | WO2008098377A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | WO2008049424A3 Pharmaceutical composition for the treatment of allergic diseases |
| 08/21/2008 | WO2008011016A3 Treating gastroesophageal reflux disease with 5-ht3- and gaba receptor agonists |
| 08/21/2008 | WO2007146425A3 Compounds and methods for treatment of chemotherapy-induced anemia |
| 08/21/2008 | US20080201789 Variants and exons of the glyt1 transporter |
| 08/21/2008 | US20080200924 Methods for minimally invasive, non-permanent occlusion of a uterine artery |
| 08/21/2008 | US20080200563 Non-invasive administering active materials; absorption iimproved using glutathione with active material; matric tablets, capsules |
| 08/21/2008 | US20080200555 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 08/21/2008 | US20080200484 Pharmaceutical Compositions Comprising A Multifunctional Phosphodiesterase Inhibitor and An Adenosine Uptake Inhibitor |
| 08/21/2008 | US20080200447 Neurotherapeutic Compositions and Method |
| 08/21/2008 | US20080200436 Antiangiogenic and/or vascular permeability reducing effect; cancer, solid tumors; kits |
| 08/21/2008 | US20080200424 Preparation for Treating Cancer |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080199865 Using allelic variation in interleukin-1RN variable number of tandem repeats as diagnostic/prognostic indicator of decrease cell division and aging characteristics |
| 08/21/2008 | US20080199864 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 08/21/2008 | US20080199856 Probe for Diagnosis of Marfan Syndrome and a Method for Screening Using the Probe |
| 08/21/2008 | US20080199529 Nanoparticle delivery vehicle |
| 08/21/2008 | US20080199487 Such as (2S,3S,4R)-1-O-( alpha -D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol; kits |
| 08/21/2008 | US20080199484 Using cyclooxgenase inhibitor as antitumor therapeutic in treatment of cell proliferative disorders |
| 08/21/2008 | US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199441 Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases |
| 08/21/2008 | US20080199438 Methods For Suppressing Tumor Proliferation |
| 08/21/2008 | US20080199429 Cell Bandage |
| 08/21/2008 | US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide |
| 08/21/2008 | US20080199424 Mart-1 t cell receptors |